WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff Relief: ... Chinese pharma firms may have escaped the immediate impact of U.S. President Donald Trump's newly announced 100% tariff on patented drugs, but longer-term threats from Wa...
(9/30/2025)

China's Biotech Deal Boom Tests Ethical Bounda... (10/31/2025)

China Pushes Ethical Limits in Global Biotech ... (10/29/2025)

Understanding China's Longevity Market: Indust... (10/22/2025)

ESMO 2025 Highlights China's Strategic Leap in... (10/21/2025)

Novo vs. KBP: Fraud or Due Diligence Slipup? (... (10/17/2025)

First Drug Patent Term Extension Granted In Ch... (10/13/2025)

U.S. Senate Approves Revised China Biotech Com... (10/13/2025)

China's Innovative Drug Sector Secures Over CN... (10/13/2025)

Challenges and Opportunities in Oncology Drug ... (9/23/2025)

China's Edge over U.S. Biotech Was Never Scien... (9/23/2025)

China's Role in Global Drug Approvals Expands ... (9/22/2025)

PRC Consolidates Pharmaceutical Supply Chain D... (9/19/2025)

CDE Invites Comment on Implementation Gu... (10/31/2025) GC Cell Licenses IASO Biotech's Multiple... (10/31/2025) Haleon Gains Momentum in China as U.S. S... (10/31/2025) China Overhauls Drug Procurement and Rei... (10/31/2025) China Adds Novel Drugs Catalog to Nation... (10/31/2025) Lumosa's Stroke Drug Achieves Phase IIb ... (10/31/2025) Junshi's Toripalimab Becomes First Immun... (10/31/2025) Roche Strikes Over $1B Global Licensing ... (10/31/2025) Longwood Biopharma Secures Series B+ Fun... (10/31/2025) Sichuan Biokin Advances 11th ADC Candida... (10/31/2025) Bayer to Divest Avelox Assets to HSG in ... (10/31/2025) Asia Regenerative Medicine Completes Ser... (10/31/2025) NMPA Grants Conditional Approval for Lep... (10/31/2025) China Issues Guidelines to Strengthen Pr... (10/29/2025) NHSA Launches Public Consultation Module... (10/29/2025) CDE Seeks Public Feedback on Draft Guide... (10/29/2025) CDE Issues Technical Guidance on Post-Ap... (10/29/2025) CDE Issues Guidance on Age-Friendly Desi... (10/29/2025)

China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B... Innovent's Weight-Loss Drug Challenges Western Giants i... China's PD-(L)1 Market Shows Continued Growth in H1 202... China to Become World's Third-Largest Innovative Drug M...

Asia Regenerative Medicine Completes Series A Funding Bayer to Divest Avelox Assets to HSG in Deal Valued up ... Longwood Biopharma Secures Series B+ Funding to Acceler... Roche Strikes Over $1B Global Licensing Deal with Qyuns... Haleon Gains Momentum in China as U.S. Sales Remain Wea...

CDE Invites Comment on Implementation Guidance for ICH ... NMPA Seeks Comments on Revised GCP Draft for Drug Trial... CDE Issues Draft Guidelines on Including Geriatric Use ... CDE Issues Guidance on Key Elements and Trial Design fo... CDE Issues Guidance on Age-Friendly Design Principles f...

China Adds Novel Drugs Catalog to National BMI Talks fo... China Overhauls Drug Procurement and Reimbursement Fram... NHSA Launches Public Consultation Module for DRG Paymen... China Issues Guidelines to Strengthen Primary Care Chro... China Sets Goal to Raise Average Life Expectancy to 80 ...

BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ... SAMR Orders Simcere to Reverse Unnotified Merger Over C...

Sanofi Launches €1B Insulin API Manufacturing Project ... China Faces New Pressure as U.S. Eyes Middle East for D... FDA Issues Warning to Chengdu Biopharma Over cGMP Viola... China's Sharp API Price Cuts Jeopardize India's Self-Re... China Produces Dozens of Drugs Below Market Price – U....

NMPA Grants Conditional Approval for Lepu Biotech's Bec... Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 int... Junshi's Toripalimab Becomes First Immunotherapy Approv... Lumosa's Stroke Drug Achieves Phase IIb Success in Chin... Abbisko Presents Promising Preclinical Data on Novel CD...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Official and Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...